Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2014 1
2016 1
2017 1
2020 3
2021 4
2022 5
2023 4
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. Kelly AS, et al. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. N Engl J Med. 2020. PMID: 32233338 Clinical Trial.
Validation of Fat Mass Metrics in Pediatric Obesity.
Lischka J, Pixner T, Mörwald K, Lauth W, Furthner D, Weghuber D, Gomahr J, Thivel D, Brandtner H, Bergauer M, Forer L, Torbahn G, Forslund A, Ciba I, Manell H, Kullberg J, Anderwald CH, Bergsten P. Lischka J, et al. Among authors: ciba i. Ann Nutr Metab. 2025;81(1):12-21. doi: 10.1159/000542029. Epub 2024 Oct 28. Ann Nutr Metab. 2025. PMID: 39467519 Free article.
Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
Furthner D, Anderwald CH, Bergsten P, Forslund A, Kullberg J, Ahlström H, Manell H, Ciba I, Mangge H, Maruszczak K, Koren P, Schütz S, Brunner SM, Schneider AM, Weghuber D, Mörwald K. Furthner D, et al. Among authors: ciba i. Front Endocrinol (Lausanne). 2022 Feb 2;13:830012. doi: 10.3389/fendo.2022.830012. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35185803 Free PMC article.
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.
Stenlid R, Cerenius SY, Wen Q, Aydin BK, Manell H, Chowdhury A, Kristinsson H, Ciba I, Gjessing ES, Mörwald K, Gomahr J, Heu V, Weghuber D, Forslund A, Bergsten P. Stenlid R, et al. Among authors: ciba i. Front Endocrinol (Lausanne). 2023 Nov 1;14:1293093. doi: 10.3389/fendo.2023.1293093. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027106 Free PMC article.
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.
Stenlid R, Cerenius SY, Manell H, Küçükemre Aydin B, Mörwald K, Gomahr J, Höghammar Mitkas M, Eriksson I, Ciba I, Geiersberger S, Thivel D, Weghuber D, Bergsten P, Forslund A. Stenlid R, et al. Among authors: ciba i. Ann Nutr Metab. 2023;79(6):522-527. doi: 10.1159/000534725. Epub 2023 Oct 26. Ann Nutr Metab. 2023. PMID: 37883939 Clinical Trial.
22 results